View in EDS

Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial.

Saved in:
Bibliographic Details
Title: Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial.
Authors: Preston, Ioana R.1 (AUTHOR) ipreston@tuftsmedicalcenter.org, Burger, Charles D.2 (AUTHOR), Bartolome, Sonja3 (AUTHOR), Safdar, Zeenat4 (AUTHOR), Krowka, Michael5 (AUTHOR), Sood, Namita6 (AUTHOR), Ford, Hubert J.7 (AUTHOR), Battarjee, Wejdan F.1 (AUTHOR), Chakinala, Murali M.8 (AUTHOR), Gomberg-Maitland, Mardi9 (AUTHOR), Hill, Nicholas S.1 (AUTHOR)
Source: Journal of Heart & Lung Transplantation. May2020, Vol. 39 Issue 5, p464-472. 9p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first